Carregant...
New Medications in the Treatment of Hereditary Transthyretin Amyloidosis
Hereditary transthyretin amyloidosis is an inherited disorder that results in the gradual progressive deposit of abnormal protein called amyloid in the body’s organs and tissues. There are currently no approved drugs to treat transthyretin amyloidosis, and patients may require liver transplantation...
Guardat en:
| Publicat a: | Hosp Pharm |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050879/ https://ncbi.nlm.nih.gov/pubmed/30038442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578718779757 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|